In short. The hair cycle explained, why follicles miniaturise, and the four main categories of hair loss that decide what treatment can actually do.

Key points

  • Two people can lose the same amount of hair for completely different reasons, and the treatments barely overlap.
  • Pattern hair loss is managed with medicines that change the cycle.
  • Alopecia areata may need immune-directed treatment.

Hair is not a single structure but a cycle of production. Every scalp hair grows from a follicle, a tiny organ set into the skin, and every follicle moves continuously through phases of growth, regression, rest and shedding. At any moment the follicles on one scalp sit at different points in that cycle, which is exactly why healthy hair is lost and replaced so gradually that nobody notices it happening.

The phases of the hair cycle

Anagen is the growth phase. Scalp follicles remain in anagen for roughly two to six years and produce about one centimetre of hair a month, so the length of this phase sets how long a person can grow their hair. Catagen is a short transition of a few weeks during which the follicle stops producing and shrinks. Telogen is a resting phase of about three months. Exogen is the shedding itself, when the resting hair is released and a new growing hair pushes through behind it.

At any time roughly nine in ten scalp follicles are growing and about one in ten are resting. Shedding fifty to a hundred hairs a day is normal rather than disease, and many people shed a little more in autumn.

How a follicle is lost

Most hair loss happens because the cycle itself changes, not because hair escapes faster. In pattern hair loss, inherited sensitivity and androgens gradually shorten the growth phase and miniaturise the follicle. Each successive cycle produces a thinner, shorter, less pigmented hair, until the follicle yields only a fine downy hair or nothing visible at all. The follicle is not destroyed, which is why treatment can partly restore it — and why treatment has to be continued to hold the result.

The four main categories

Almost every case belongs to one of four groups, and the group decides the treatment. Pattern hair loss is androgen-driven and inherited, and it is by far the most common. Immune-mediated hair loss, alopecia areata, is an autoimmune attack on the follicle. Shedding conditions such as telogen effluvium follow a stressor and are usually temporary. Scarring alopecia destroys the follicle permanently through inflammation and fibrosis, and it is the group in which delay causes irreversible damage. A fifth and purely structural problem, breakage and traction damage, often coexists with the others.

Why the category comes first

Two people can lose the same amount of hair for completely different reasons, and the treatments barely overlap. Pattern hair loss is managed with medicines that change the cycle. Alopecia areata may need immune-directed treatment. Telogen effluvium usually needs time and correction of a cause. Scarring alopecia needs a biopsy and urgent anti-inflammatory treatment. Guessing wastes the months that matter most.

What this means in practice

Hair grows slowly, so it also responds slowly. A treatment that genuinely works still needs six to twelve months before the response can be judged fairly, and it must be continued to keep whatever it has regained.

Arrange a dermatology assessment if

  • Loss is patchy or sudden, or the scalp itches, burns, scales or reddens alongside it.
  • You can see a widening parting, a receding hairline, or thinning that is clearly progressing.
  • An area of scalp looks smooth and shiny, or the eyebrows and eyelashes are thinning — do not wait.

Related reading

Frequently asked questions

How much hair loss per day is normal?

Fifty to a hundred hairs a day is normal rather than disease. At any time roughly nine in ten scalp follicles are growing and about one in ten are resting, and many people shed a little more in autumn.

Why does pattern hair loss not destroy the follicle?

Because the cycle changes rather than the follicle dying. Inherited sensitivity and androgens shorten the growth phase and miniaturise the follicle, so each cycle yields a thinner, shorter hair. The follicle survives, which is why treatment can partly restore it and must be continued to hold the result.

Why does the category of hair loss matter so much?

Because the treatments barely overlap. Pattern hair loss is managed with medicines that change the cycle, immune-mediated loss may need immune-directed treatment, shedding conditions usually need time and a corrected cause, and scarring alopecia needs a biopsy and urgent anti-inflammatory treatment.

Risks & Limitations

  • Most hair loss is progressive and managed rather than reversed; treatment holds the line more often than it restores it.
  • Treatment takes 6–12 months before a response can be judged fairly, and must usually be continued indefinitely to keep the result.
  • Stopping treatment commonly means losing the hair that was regained, usually within months.
  • Some oral agents cause sexual, mood and metabolic side effects, and several require blood monitoring, blood-pressure monitoring, or pregnancy prevention.
  • Hair transplantation moves existing hair; it does not create new hair and does not stop the underlying process.
  • Scarring alopecia destroys the follicle permanently, so hair lost before treatment begins cannot be recovered.
  • No treatment works for everyone, and response cannot be predicted with certainty.

When to Seek Care

  • Sudden patchy hair loss, especially with scalp redness, scaling, itching or pain.
  • Hair loss with fever, joint pain, mouth ulcers, or a rash elsewhere on the body.
  • Scarring changes: an area of scalp that has become smooth, shiny or pale, with loss of the follicular openings.
  • Eyebrow or eyelash loss, which suggests a more extensive or systemic process.
  • Hair loss with fatigue, palpitations, weight change, or heavy or irregular periods — a systemic cause needs excluding.

References & Further Reading

  • American Academy of Dermatology (AAD) — public and clinical guidance on hair and scalp disorders
  • Chinese Medical Association, Dermatology Branch — clinical guidance
  • Cochrane Library — systematic reviews in dermatology
  • World Health Organization (WHO) — general health and nutrition resources

Medically reviewed by Yongbo Jia, MD (贾勇波), Deputy Director & Head of Dermatology. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.